S100-A10, thioredoxin, and S100-A6 as biomarkers of papillary thyroid carcinoma with lymph node metastasis identified by MALDI imaging. (Q34027466)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21938494%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

title

S100-A10, thioredoxin, and S100-A6 as biomarkers of papillary thyroid carcinoma with lymph node metastasis identified by MALDI imaging (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21938494%20AND%20SRC:MED&resulttype=core&format=json

matrix-assisted laser desorption/ionization

13 February 2020

main subject

0 references

biomarker

0 references

lymph node

0 references

papillary thyroid cancer

1 reference

inferred from title

lymph node metastasis

1 reference

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21938494%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

6

Marius Ueffing

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21938494%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

author name string

Martin Nipp

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21938494%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Mareike Elsner

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21938494%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Benjamin Balluff

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21938494%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Stephan Meding

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21938494%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Hakan Sarioglu

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21938494%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Sandra Rauser

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21938494%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Heinz Höfler

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21938494%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Axel Walch

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21938494%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Horst Zitzelsberger

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21938494%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

publication date

22 September 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21938494%20AND%20SRC:MED&resulttype=core&format=json

Journal of Molecular Medicine

13 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21938494%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

volume

90

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21938494%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21938494%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

page(s)

163-174

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21938494%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00109-011-0815-6

13 February 2020

exact match

0 references

cites work

New therapeutic approaches for metastatic thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0815-6

Controversies in the management of thyroid nodule

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0815-6

BRAF mutation testing of thyroid fine-needle aspiration biopsy specimens for preoperative risk stratification in papillary thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0815-6

Early changes in protein expression detected by mass spectrometry predict tumor response to molecular therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0815-6

Imaging mass spectrometry of a specific fragment of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase 2 discriminates cancer from uninvolved prostate tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0815-6

MALDI imaging combined with hierarchical clustering as a new tool for the interpretation of complex human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0815-6

Concise representation of mass spectrometry images by probabilistic latent semantic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0815-6

Toward digital staining using imaging mass spectrometry and random forests.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0815-6

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0815-6

Differential exoprotease activities confer tumor-specific serum peptidome patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0815-6

Identification of markers of taxane sensitivity using proteomic and genomic analyses of breast tumors from patients receiving neoadjuvant paclitaxel and radiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0815-6

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0815-6

Frequency of BRAF T1796A mutation in papillary thyroid carcinoma relates to age of patient at diagnosis and not to radiation exposure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0815-6

Classification of HER2 receptor status in breast cancer tissues by MALDI imaging mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0815-6

Differentiating proteomic biomarkers in breast cancer by laser capture microdissection and MALDI MS

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0815-6

Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0815-6

B-Raf(V600E) and thrombospondin-1 promote thyroid cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0815-6

Mutational profile of advanced primary and metastatic radioactive iodine-refractory thyroid cancers reveals distinct pathogenetic roles for BRAF, PIK3CA, and AKT1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0815-6

Progression of BRAF-induced thyroid cancer is associated with epithelial-mesenchymal transition requiring concomitant MAP kinase and TGFβ signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0815-6

Gene expression and functional evidence of epithelial-to-mesenchymal transition in papillary thyroid carcinoma invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0815-6

KiSS-1/G protein-coupled receptor 54 metastasis suppressor pathway increases myocyte-enriched calcineurin interacting protein 1 expression and chronically inhibits calcineurin activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0815-6

Genome-wide profiling of papillary thyroid cancer identifies MUC1 as an independent prognostic marker.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0815-6

S100A6 protein as a marker for differential diagnosis of cholangiocarcinoma from hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0815-6

Differential expression patterns of S100A2, S100A4 and S100A6 during progression of human malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0815-6

Quantitative and qualitative differences in protein expression between papillary thyroid carcinoma and normal thyroid tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0815-6

Increased expression of S100A6 at the invading fronts of the primary lesion and liver metastasis in patients with colorectal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0815-6

The role of S100A6 in pancreatic cancer development and its clinical implication as a diagnostic marker and therapeutic target.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0815-6

Calcyclin (S100A6) regulates pulmonary fibroblast proliferation, morphology, and cytoskeletal organization in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0815-6

Proteomic study of thyroid tumors reveals frequent up-regulation of the Ca2+ -binding protein S100A6 in papillary thyroid carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0815-6

S100A10, annexin A2, and annexin a2 heterotetramer as candidate plasminogen receptors

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FS00109-011-0815-6

21 January 2018

12 December 2020

Targeting urokinase-type plasminogen activator and its receptor for cancer therapy

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0815-6

Thioredoxin regulates cell cycle via the ERK1/2-cyclin D1 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0815-6

Thioredoxin signaling as a target for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0815-6

TGFbeta signaling in growth control, cancer, and heritable disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0815-6

Role of transforming growth factor Beta in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0815-6

Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0815-6

TGF-beta3 and cancer: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0815-6

A proteomic approach to immune-mediated epithelial-mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0815-6

Transforming growth factor-beta and epidermal growth factor synergistically stimulate epithelial to mesenchymal transition (EMT) through a MEK-dependent mechanism in primary cultured pig thyrocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0815-6

Plasminogen is present in the basal layer of the epidermis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0815-6

The plasminogen activation system in tumor growth, invasion, and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0815-6

TGF-beta signaling in cancer--a double-edged sword

21 January 2018

1 reference

12 December 2020

Increasing incidence of thyroid cancer in the United States, 1973-2002

1 reference

12 December 2020

Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer

1 reference

12 December 2020

Plasminogen activation and cancer

1 reference

12 December 2020

An aggressive radio-resistant papillary thyroid cancer

1 reference

12 December 2020

Identifying prostate carcinoma by MALDI-Imaging.

1 reference

12 December 2020

Papillary microcarcinoma of the thyroid-Prognostic significance of lymph node metastasis and multifocality

1 reference

12 December 2020

High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma

1 reference

12 December 2020

Improvement of an "In-Gel" digestion procedure for the micropreparation of internal protein fragments for amino acid sequencing

1 reference

12 December 2020

High nuclear S100A6 (Calcyclin) is significantly associated with poor survival in pancreatic cancer patients

1 reference

12 December 2020

Expression of S100A2 and S100A6 in thyroid carcinomas

1 reference

12 December 2020

Proteomic analysis of lung adenocarcinoma: identification of a highly expressed set of proteins in tumors.

1 reference

12 December 2020

Molecular profiling of matched samples identifies biomarkers of papillary thyroid carcinoma lymph node metastasis

1 reference

12 December 2020

Impact of nodal metastases on prognosis in patients with well-differentiated thyroid cancer

1 reference

12 December 2020